Naoko Inoshima

911 citations
8 papers · 508 indexed · h-index 6
Topics
Immunotherapy and Immune Responses (2 papers)Clostridium difficile and Clostridium perfringens research (2 papers)Antimicrobial Resistance in Staphylococcus (2 papers)
Partner nations
JapanAustraliaChina

In The Last Decade

Naoko Inoshima

8 papers receiving 499 citations

Peers

Naoko Inoshima
Comparison fields: 5 of 65
  • Infectious Diseases 247
  • Molecular Biology 226
  • Immunology 145
  • Epidemiology 78
  • Oncology 65
Replace Pramod Giri with:
Pramod Giri United States
Nicole Meissner United States
Jaffre J. Athman United States
Klára Megyeri Hungary
Christian Blank Germany
Denise A. Croix United States
Jesús Colino United States
Debra Tross United States
Lars Vitved Denmark
Cassandra C. Paul United States
Naoko Inoshima relative to Pramod Giri United States Pramod Giri's profile →
Citations per field
00.5×1.5×2.4×
Pramod Giri · 1×
Citations per year

Countries citing papers authored by Naoko Inoshima

Since Specialization
Citations

This map shows the geographic impact of Naoko Inoshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Inoshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Inoshima more than expected).

Fields of papers citing papers by Naoko Inoshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Inoshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Inoshima. The network helps show where Naoko Inoshima may publish in the future.

Co-authorship network of co-authors of Naoko Inoshima

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Inoshima. A scholar is included among the top collaborators of Naoko Inoshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Inoshima. Naoko Inoshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 325
2 15
3 63
4
Adenovirus-mediated inhibitor kappaB gene transfer improves the chemosensitivity to anticancer drugs in human lung cancer in vitro and in vivo.
5
5
Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tumorigenesis and angiogenesis in vivo.
9
6
[Epidemiological trends in lung cancer in Japan].
1
7
The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer.
87
8 3

About Naoko Inoshima

Naoko Inoshima is a scholar working on Microbiology, Immunology and Allergy and Infectious Diseases, having authored 8 papers that have together received 508 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Infectious Diseases (247 citations), Microbiology (63 citations) and Immunology (145 citations). Naoko Inoshima has collaborated with scholars based in Japan, Australia and China. Frequent co-authors include Georgia Wilke, Ichiro Inoshima, Juliane Bubeck Wardenburg, Karen M. Frank, Yang Wang, Michael E. Powers, Yoichi Nakanishi, Takahiro Minami, Koichi Takayama and Nobuyuki Hara. Their work appears in journals such as Nature Medicine, European Journal of Cancer and Respirology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026